ct-011
Showing 1 - 8 of 8
Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)
Active, not recruiting
- Multiple Myeloma
- CT-011
- Dendritic Cell Fusion Vaccine
-
Boston, Massachusetts
- +2 more
Sep 5, 2022
Pancreatic Tumors, Cancer of the Pancreas, Tumors Pancreatic Trial in Augusta (CT-011, Gemcitabine)
Terminated
- Pancreatic Neoplasms
- +4 more
- CT-011
- Gemcitabine
-
Augusta, GeorgiaGeorgia Regents University
Jun 18, 2019
Breast Cancer, Colon Cancer, Pancreatic Cancer Trial run by the NCI (p53: 264-272 peptide, CT-011)
Withdrawn
- Breast Cancer
- +4 more
- p53: 264-272 peptide
- CT-011
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Renal Cell Carcinoma Trial in Boston (CT-011, DC/RCC fusion vaccine)
Terminated
- Renal Cell Carcinoma
- CT-011
- DC/RCC fusion vaccine
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Dec 15, 2016
Lymphoma Trial in Houston (CT-011, Rituximab)
Completed
- Lymphoma
- CT-011
- Rituximab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 27, 2016
Melanoma, Malignant Melanoma Trial in Israel, United States (CT-011)
Completed
- Melanoma
- Malignant Melanoma
- CT-011
-
New Haven, Connecticut
- +17 more
Dec 16, 2015
Lymphoma, Large Cell, Diffuse, Lymphoma, Mixed Cell, Diffuse, Primary Mediastinal Large B-Cell Lymphoma Trial in India, Israel,
Completed
- Lymphoma, Large Cell, Diffuse
- +2 more
- CT-011
-
La Jolla,, California
- +26 more
Sep 8, 2014